A detailed history of Quantamental Technologies LLC transactions in Novavax Inc stock. As of the latest transaction made, Quantamental Technologies LLC holds 13,308 shares of NVAX stock, worth $112,718. This represents 0.09% of its overall portfolio holdings.

Number of Shares
13,308
Holding current value
$112,718
% of portfolio
0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$6.81 - $9.74 $90,627 - $129,619
13,308 New
13,308 $96,000
Q2 2022

Aug 15, 2022

BUY
$36.28 - $75.29 $329,204 - $683,181
9,074 New
9,074 $467,000
Q3 2019

Nov 08, 2019

SELL
$4.02 - $7.84 $960 - $1,873
-239 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$4.93 - $12.2 $1,178 - $2,915
239 New
239 $1,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $662M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.